Home Cycle Dianabol Clenbuterol, Clenbuterol Y Ambroxol CIPM Ikeja Study Center
A Practical Guide to the Use of Echinacea purpurea ("Echinacea") in Performance‑Enhancing Protocols
---
1. Why Echinacea?
The perennial herb Echinacea purpurea (commonly called "Echinacea" or "purple coneflower") has long been employed in traditional medicine to boost the immune system and to shorten the duration of common colds. In a sports‑nutrition context, two properties are especially relevant:
Property Relevance for Athletes
Immunomodulation – enhances NK cell activity & reduces pro‑inflammatory cytokines (IL‑6, TNF‑α) Limits infection risk during heavy training loads and accelerates recovery from inflammation.
A 2020 meta‑analysis of 15 randomized controlled trials (RCTs) found that Artemisia supplementation significantly reduced markers of systemic inflammation and improved subjective measures of fatigue in athletes.
---
2. Proposed Clinical Trial Design
Element Details
Study type Randomized, double‑blind, placebo‑controlled, parallel‑group trial
Participants Male & female endurance athletes aged 18–45 years who train ≥5 h/week.
Sample size 120 participants (60 per arm). Power calculation: α = 0.05, β = 0.80, effect size f = 0.25 for primary outcome (VO₂max change) → ~48 per group; adding 20% attrition yields 60 per group.
Intervention Oral capsules containing standardized extract of Artemisia annua (100 mg artemisinin equivalent + 400 mg total polyphenols) taken twice daily with meals.
Control Matching placebo capsule.
Duration 12 weeks.
| Outcome Measures
Primary: Change in VO₂max (ml/kg/min) measured by graded exercise test at baseline and week 12.
Secondary:
- Maximal oxygen uptake per body mass vs. lean mass. - Time to exhaustion, lactate threshold. - Markers of oxidative stress: plasma F2-isoprostanes, 8‑oxo‑dG. - Antioxidant capacity: FRAP assay, total antioxidant status. - Inflammatory cytokines (IL‑6, TNF‑α). - Blood flow dynamics: Doppler ultrasound of femoral artery pulse wave velocity. - Metabolomic profiling of blood and urine (LC‑MS/MS) for oxidative stress metabolites.
Statistical Analysis:
Intention‑to‑treat principle.
Mixed‑effects linear models with fixed effects for treatment, time, and their interaction; random intercepts for participants.
Adjusted p‑values using Benjamini–Hochberg false discovery rate for multiple testing (especially in metabolomics).
Effect sizes expressed as Cohen’s d and 95% confidence intervals.
Potential Impact:
By rigorously quantifying how oxidative stress influences cardiovascular function, the study will clarify whether antioxidant therapies could be beneficial or harmful. The mechanistic insights into endothelial dysfunction may inform precision medicine strategies to mitigate CVD risk in populations with high oxidative burdens (e.g., smokers, diabetics). Moreover, the methodology—integrating clinical phenotyping with metabolomic profiling—could serve as a template for investigating other complex disease processes where redox biology plays a pivotal role.